Healthcare Transaction Brief: AfricInvest and Proparco Invest $2.99m in Lapaire Glasses

Transaction Summary

AfricInvest ($2.5m) and Proparco (€450,000) have approved a $2.99 million debt financing for Lapaire Glasses Kenya Limited. This optical retail chain provides free eye tests and affordable eyewear across Francophone West Africa and East Africa using a network of 80+ shops. This financing aims to enhance Lapaire's operational capabilities across Côte d'Ivoire, Benin, Togo, Mali, Burkina Faso, and Uganda and expand its market presence to Senegal, the D.R. of Congo and Tanzania. The deal is one of 3 early commitments from the Transform Health Fund, a blended-finance debt fund closed by AfricInvest and The Health Finance Coalition, of which Proparco is also a Limited Partner. 

Terms:

  • Fund Managers: AfricInvest and Proparco
  • Funds: Transform Health Fund (AfricInvest) and The Bridge Fund by Digital Africa (Proparco)
  • Target Company: Lapaire Glasses SA
  • Transaction Type: Debt
  • Investment Amount: $2.99m

Transaction Rationale

Commercial funding has fallen short in addressing the financing needs of Africa’s healthcare sector. Despite Africa

This story is only available to Premium subscribers Subscribe or sign in to finish reading

Not ready to subscribe? Register to read a selection of free stories

Stears Reports

Stears Reports

Read Latest

Healthcare Transaction Brief: Saviu Ventures sells its 22% stake in Lapaire Glasses to Creadev

PREMIUM - 03 FEB 2025

Weekly Africa Macro Update: January 27-31, 2025

PREMIUM - 03 FEB 2025

Agriculture Transaction Brief: BII raises equity stake in Valency International with $15M

PREMIUM - 31 JAN 2025

Energy Transaction Brief: IFU invests $15 million in PowerGen

PREMIUM - 30 JAN 2025

Download our mobile app for a more immersive reading experience

Scan QR code
mobile download